By proceeding, you agree to our Terms of Use and Privacy Policy.
The 10th Neurodegenerative Disease Drug Development Summit will be discussing, debating and exploring pivotal neurodegenerative disease research from the past 12 months.
Witness the exceedingly challenging and exciting field of neurodegenerative drug development to revolutionize this space in 2022.
With the speakers, leverage data from clinical samples to catalyze the next generation of therapies against Alzheimer’s and Parkinson’s disease.
Network with speakers and clinical experts to unravel the complexities of neurodegenerative drug development to scale your business and research.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
bit.bio is an award-winning human synthetic biology enterprise based in Cambridge, UK. bit.bio's mission is to code cells for health. Our breakthrough opti-ox technology platform is capable of producing consistent batches of every human cell.
Fluidic Analytics – Understand the Machinery of Life.
Certara accelerates medicines using proprietary biosimulation software and technology to transform traditional drug discovery and development.
Atuka provides contract research and consultancy services for the biopharmaceutical industry with world-leading expertise in Parkinson's disease and other neurological conditions.
Genomenon is a genomic health IT company that keeps pace with the constant advancements made in genomics and connects that research to patient DNA to help diagnose and treat patients with rare genetic diseases and cancer.
Olink offers an unmatched high-multiplex technique to identify actionable biomarkers, with a strong focus on the human plasma proteome.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.